Mark W Douglas

20PUBLICATIONS
46CO-AUTHORS
AllergyNeural engineeringMultimorbidityMedical biochemistry - lipidsGene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (20)

|Nov 07, 2025
Elebsiran and PEG-IFNα for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial.

Grace Lai-Hung Wong, Man-Fung Yuen, Bingliang Lin

|Nov 12, 2024
Telehealth Use and Legal Considerations in Drug Health Services During Pandemics: Systematic Scoping Review.

Meryem Jefferies, Robert Graham, Marguerite Tracy

|Apr 23, 2024
Hepatitis C Virus Antiviral Drug Resistance and Salvage Therapy Outcomes Across Australia.

Dao Sen Wang, Amy Phu, Kristen McKee

|Feb 26, 2024
Inhibition of Cellular Factor TM6SF2 Suppresses Secretion Pathways of Hepatitis B, Hepatitis C, and Hepatitis D Viruses.

Thomas Tu, Harout Ajoyan, Rifqiyah Nur Umami

Pageof 4